Breckenridge Pharmaceutical has issued a significant voluntary recall affecting over 375,000 bottles of Duloxetine Delayed-Release Capsules, an SNRI medication commonly prescribed for depression, anxiety, and neuropathic pain. The recall, initiated in June 2026, marks the latest in a series of market withdrawals by the company over the past two years relating to the same safety concern.
The Cause: Nitrosamine Impurities
The core issue driving the recall is the detection of N-nitroso-duloxetine, a nitrosamine impurity found in the affected batches at levels that exceed the strict daily intake limits recommended by the U.S. Food and Drug Administration (FDA).
Nitrosamines are common compounds found in water and everyday foods, including cured and grilled meats. However, prolonged exposure to these impurities at higher-than-acceptable levels over long periods can increase the risk of cancer, leading regulatory agencies to strictly monitor their presence in pharmaceutical products.
Details of the Current Recall
The June 2026 recall specifically targets multiple lots of the medication, encompassing both the 30mg and 60mg dosages:
- 30mg Capsules: Identified under NDC 51991-747-10.
- 60mg Capsules: Identified under NDC 51991-748-90 and NDC 51991-748-10.
The expiration dates on the affected bottles range from November 2026 through May 2027.
This is not an isolated incident for Breckenridge Pharmaceutical. The company navigated a series of similar, large-scale recalls throughout 2024 and 2025 as the pharmaceutical industry at large continues to grapple with the complex challenge of nitrosamine contamination in drug manufacturing processes.
Critical Patient Guidance
For patients currently taking duloxetine, the FDA and healthcare professionals emphasize one critical directive: Do not stop taking your medication abruptly.
Duloxetine is known to cause severe withdrawal symptoms-often referred to as discontinuation syndrome-if stopped suddenly. Symptoms can include dizziness, nausea, headache, paresthesia (brain zaps), and intense mood fluctuations.
If you are taking Breckenridge-manufactured duloxetine, you should take the following steps:
- Check your bottle: Look for the manufacturer name (Breckenridge Pharmaceutical) and the lot number on your prescription label.
- Contact your pharmacist: If the lot number matches the recalled batches, your pharmacist can verify the recall and provide a safe replacement from an unaffected batch or a different manufacturer.
- Consult your doctor: Discuss any concerns about your treatment plan or potential alternatives with your prescribing physician.
Maintaining patient safety while avoiding the risks of sudden drug discontinuation remains the highest priority for healthcare providers managing this ongoing recall.
Pharmaceutical Quality Control and Batch Recalls
Breckenridge Pharmaceutical's voluntary recall of several lots of Duloxetine Delayed-Release Capsules highlights the critical role of product stability testing in quality assurance. The recall was initiated after routine stability testing detected the presence of an impurity (N-nitroso-duloxetine) above the acceptable daily intake limit set by regulatory authorities. Nitrosamines are classified as probable human carcinogens, and their presence in common medications has triggered numerous recalls in recent years.
This recall requires pharmacies, distributors, and patients to immediately check their stock and return affected lots. For manufacturers, it emphasizes the importance of verifying raw material purity and validating chemical synthesis routes to prevent the formation of nitrosamine impurities during production and storage.
Frequently Asked Questions
What medication was recalled by Breckenridge Pharmaceutical?
Breckenridge recalled specific lots of Duloxetine Delayed-Release Capsules, a medication commonly prescribed to treat major depressive disorder and generalized anxiety disorder.
Why was the Duloxetine recall initiated?
The recall was triggered because testing identified levels of a nitrosamine impurity (N-nitroso-duloxetine) that exceeded the acceptable daily limit set by the FDA.
What should patients do if they have the recalled medication?
Patients should check the lot numbers on their prescription bottles. If they match the recalled lots, they should contact their pharmacy or physician for a replacement, and should not stop taking their medication without consulting their doctor.
Frequently Asked Questions
What are nitrosamines and why are they dangerous?
Nitrosamines are chemical compounds that are classified as probable human carcinogens. Long-term exposure to levels above acceptable limits may increase the risk of cancer.
Are all batches of Breckenridge Duloxetine affected?
No. The recall is limited to specific lot numbers and expiration dates identified in the manufacturer's official recall announcement.
What is the therapeutic class of Duloxetine?
Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat depression, generalized anxiety disorder, and diabetic peripheral neuropathy.
Frequently Asked Questions
What are nitrosamines and why are they dangerous?
Nitrosamines are chemical compounds that are classified as probable human carcinogens. Long-term exposure to levels above acceptable limits may increase the risk of cancer.
Are all batches of Breckenridge Duloxetine affected?
No. The recall is limited to specific lot numbers and expiration dates identified in the manufacturer's official recall announcement.
What is the therapeutic class of Duloxetine?
Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat depression, generalized anxiety disorder, and diabetic peripheral neuropathy.
